Sep 2026· International Journal of Hematology-Oncology and Stem Cell Research· 0 citations
TL;DR
It is indicated that the combination of hypoxia and LPS treatment affects the proliferative capacity of UC-MSCs, thus enhancing the MSC migration rate, and hypoxia and LPS together reduce the expression of paracrine factors in UC-MSCs, potentially attenuating the immunomodulatory efficacy of UC-MSCs in tissue injury microenvironments.
Abstract
Background: Mesenchymal stem cells (MSCs) have emerged as a promising strategy for tissue regeneration. Although hypoxia or lipopolysaccharide (LPS) has been shown to affect the regenerative capacity of MSCs, their combined effects on MSCs are still unknown. We examined the effects of hypoxia and LPS on MSC migration rates and paracrine expression.
Materials and Methods: Umbilical cord-derived MSCs (UC-MSCs) were isolated and characterized. Wound scratch assays assessed migration and proliferation under hypoxic conditions, LPS supplementation, or both. The expression of paracrine factors was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR).
Results: Twenty-four hours post-scratching, the gap closure in UC-MSCs after both hypoxia exposure and LPS treatment was significantly enhanced than those in the control group (p=0.008) or those subjected to individual treatments (p=0.028 vs. hypoxia and p=0.0021 vs. LPS). Serum-supplemented media further maximized these synergistic effects. Combined hypoxia and LPS did not affect vascular endothelial growth factor (VEGF) mRNA levels. In contrast, both hypoxia exposure and LPS treatment decreased the transcript levels of hepatocyte growth factor (HGF), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and transforming growth factor-β (TGF-β).
Conclusion: These findings indicate that the combination of hypoxia and LPS treatment affects the proliferative capacity of UC-MSCs, thus enhancing the MSC migration rate. However, hypoxia and LPS together reduce the expression of paracrine factors in UC-MSCs, potentially attenuating the immunomodulatory efficacy of UC-MSCs in tissue injury microenvironments.
ABSTRACT Purpose: Acute lung injury (ALI) is a severe pulmonary disorder with limited treatment options. Mesenchymal stem cell-based therapies show regenerative and immunomodulatory potential, but the comparative efficacy of adipose-derived mesenchymal stem cells (ADMSCs) and their exosomes remains unclear. This study...
Gamze Ayar, Badel Ince, K. Büyükafşar et al.· Acta Cirurgica Brasileira· 0 citations
Diabetic wounds are closely associated with persistent oxidative stress, decreased fibroblast activity, and delayed tissue regeneration under hyperglycemic conditions. These pathological features particularly complicate wound healing and often lead to chronic non-healing wounds. Recently, mesenchymal stem cells (MSCs)...
Mesude Biçer, Mert Akdur, Esra Battal et al.· ACS Omega· 0 citations
Background: Mesenchymal stromal cells (MSCs) are among the most extensively studied candidates for cell-based therapy. The homing capacity of MSCs is a critical factor influencing the efficacy of MSC-based therapies. This study aimed to investigate the homing of placenta-derived mesenchymal stromal cells (PD-MSCs) in v...
Nasser Ahmadbeigi, S. Muhammadnejad, A. Muhammadnejad et al.· Advanced Biomedical Research· 0 citations
Cell culture media specifically formulated to promote the growth of mesenchymal stem cells (MSCs) are essential for the clinical application of these cells. The biological effects of selenium on MSCs are related to its form, but it is not yet determined which form of selenium is more effective for the cultivation of MS...
Bei-Bei Ni, Hua-Li Li, Rui-Xuan Xu et al.· Journal of Trace Elements in...· 0 citations
Human umbilical cord mesenchymal stromal cells (UCMSCs) are multipotent stem cells with strong immunomodulatory capacity, ease of acquisition, low immunogenicity, and a non-tumorigenic nature, making them attractive candidates for tissue repair. Under standard culture conditions, cells within a population exist in va...
Introduction: Intervertebral disc (IVD) degeneration is a major cause of low back pain, and is characterized by the loss of extracellular matrix, particularly type II collagen. Regenerative therapies using mesenchymal stem cells (MSCs) and their secretome have shown promise, but their comparative effects on type II col...
Romaniyanto Romaniyanto, Dykall Dzikri, Daffa Sadewa et al.· Cermin Dunia Kedokteran· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.